InvestorsHub Logo

rodman

03/22/19 8:20 AM

#175245 RE: misanthrope #175243

Guess thats your opinion which is cool! Some savy investors have bot and sold Biel over the years and are still invested at an average price of .00067 Thats COOL I can live with that and the future! Create losses and make gains! Try it!

pinhigh

03/22/19 8:23 AM

#175247 RE: misanthrope #175243

Any Big Pharma who envisions Actipatch becoming a Standard of Care would be getting the steal of a lifetime if they were able to purchase Biel for 250 million. Most longs here who understand the product's potential would hate to see it sold for such a sum. Something tells me AW feels the same way. Go Biel$$$

art2426

03/22/19 12:46 PM

#175312 RE: misanthrope #175243

I agree and disagree with points in your post. I agree that we as stockholders would not want to see a sale or buyout at this time while we are trading at .0008. That would be the starting price in any negotiations with a buyer, as .0008 is what the market is valuing the company at, right now. Like it or not an offer from buyer starts there. Same scenario if/when the price gets higher as THAT would be the starting figure in negotiations. That is why IMO it is SO important to get the stock price higher for when any talks of sale might happen.

I disagree that .01, at $250 million sale could not happen. With the immense resources that a major player in the pain business has, they will envision so many more clearances they could get for so many more uses these products and PATENTS could provide. The key word is PATENTS. THEY IMO are worth north of 250 mil to one with resources that CAN and will capitalize on all that 'can be accomplished' due to those patents. And due to such financial resources, much faster than we are experiencing now with this cash strapped company.